… Multiple trials over the past several years have examined the effects of both angiotensin-converting
enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) in the …

… to 2.3-fold higher among patients with diabetic retinopathy than … angiotensin–aldosterone
system with angiotensin-converting-enzyme (ACE) inhibitors or angiotensin II receptor blockers …

… To compare the efficacy and safety of angiotensin-converting enzyme inhibitors (ACEis) and
angiotensin receptor blockers (ARBs) in patients … angiotensin-converting enzyme inhibitor …

… suggested that angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor
blockers (… Therefore, caution has been advised when switching patients with ACEi-related …

… Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs)
are the two major classes of drugs among renin-angiotensin system (RAS) inhibitors, and …

… are the preferred antihypertensive medications in patients with diabetes and prior stroke. …
of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs…

… the available evidence to compare angiotensin-converting enzyme (ACE) inhibitors with
angiotensin II receptor blockers (ARBs) on improving insulin sensitivity in hypertensive patients. …

… that angiotensin converting enzyme inhibitor (ACEI) and angiotensin II receptor blocker (…
In this retrospective, single-center US study of adult patients diagnosed with COVID-19, we …

… 188 patients with hypertension who taking ACEI (angiotensin-converting enzyme inhibitor)
or ARB (angiotensin II receptor blocker) during hospitalization were enrolled in the ACEI/ARB …

… , and pulmonary alveolar (type II) cells [Citation2]. Several animal models have shown
that angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) …